Jakob Emerson Speaking Medicare Advantage & Prior Authorization

In this episode of the Becker's Healthcare Podcast, host Scott Becker interviews Jacob Emerson, a leading expert on the payer landscape, to unpack two critical issues in U.S. healthcare: Medicare Advantage (MA) and prior authorization. Emerson details CMS's final 2027 Medicare Advantage rule, highlighting a 2.48% rate increase—equivalent to $13 billion in additional funding—but notes that the effective increase is closer to 5% due to risk score adjustments. He emphasizes that while the government remains fully committed to MA as the dominant Medicare delivery model, CMS is now cracking down on upcoding through a 6% coding pattern adjustment and banning unlinked chart reviews, which were used to inflate patient diagnoses for higher payments. This signals growing federal scrutiny of overpayment practices, despite the financial boost to insurers. On prior authorization, Emerson discusses both CMS’s regulatory mandates and a voluntary industry pledge to streamline the process. While the industry claims to have eliminated 11% of commercial and 15% of MA prior auth requirements, he cautions that the data released on insurer websites is too broad and opaque to be useful for patients. He draws a parallel to price transparency rules, noting that compliance doesn’t equate to usability, underscoring a recurring gap between policy intent and real-world impact. Overall, the conversation reveals a system where structural incentives favor insurers, and regulatory efforts often fall short of meaningful change for providers and patients.